Raising
Board dynamics
Healthy boards argue about strategy. Unhealthy boards rubber-stamp — or turn every meeting into a referendum on the CEO.
Healthy boards argue. Unhealthy boards either rubber-stamp or turn every meeting into a referendum on the CEO. Know what actually requires board approval versus what is CEO judgment. Escalating every product debate to the board weakens you; hiding decisions that do require approval blows up trust.
You paid for more than money (in dilution). Good investors help with hiring, customers, follow-on capital and pattern recognition. Make help easy: forwardable blurbs, clear role specs, named target companies. After an intro, close the loop so they know whether to spend social capital again. Not every investor is good at this. Score them privately and spend CEO time accordingly.
The big idea
| Pattern | What it looks like | What to do |
|---|---|---|
| Growth vs efficiency | Investor pushes hire-ahead; you see burn risk | Bring a two-scenario model to the meeting |
| Founder conflict | Co-founders disagree in front of the board | Align privately first; board is not couples therapy |
| Investor conflict | Two funds want different paths | Restate fiduciary duty to the company; use independents |
| Control creep | Every operational detail becomes a board topic | Push ops to updates; reserve board for strategy and governance |
Trade-off
Founder-controlled board vs investor-heavy board. Founder control preserves speed and narrative ownership but can delay hard accountability. Investor majority can help in a CEO transition or crisis but raises the cost of disagreement on vision. At seed, push for structures that leave founders with practical control while giving the lead a real seat and information rights — details in control terms.
Your investor may sit on a competitor's board or be evaluating one. Assume sensitive roadmap details can travel unless you have a clear understanding otherwise. Share what helps them help you; keep crown-jewel unpublished strategy for a smaller circle. When a true conflict appears, name it early and ask how they want to handle recusal.
Partners have 10–20+ active companies. A 45-minute "brain dump" call with no agenda wastes their scarcest resource. Send three bullets and one decision or ask before you dial.
Walking through a founder split
The CEO wants to take a term sheet. The other founder wants to wait for another quarter of metrics. If they argue it live, directors spend the meeting refereeing a partnership, not governing a company. The night before, the two founders either agree on one recommendation or write a one-page options memo: take the sheet, wait 90 days, or run a short competitive process. The board then decides among options, not personalities.
When two funds want different paths — one hire-ahead, one cut-to-default-alive — restate that fiduciary duty is to the company, not to either fund's remaining dry powder. An independent director is the person who can say that out loud.
Common mistakes
- Founder conflict in the room. Align privately; bring one recommendation.
- Letting ops fill the agenda. Strategy and governance belong here; hiring standups do not.
- Assuming every investor adds operating value. Some only show up for votes. Spend time on the ones who help.
Check yourself
You and your co-founder disagree on the round. The board meeting is tomorrow. What do you do tonight?
Align on one recommendation, or name the disagreement as a decision with options. Do not surprise directors with a live fight.
A partner wants a weekly product review after a $200k seed check. What is off?
Control creep. Push ops to the monthly update; reserve the board for strategy and votes.
Key takeaways
- Argue about strategy on the board; align founder conflicts privately.
- Fiduciary duty is to the company when funds disagree — independents help.
- Use investors with forwardable asks; track who actually helps.
- Assume portfolio conflict; name recusal early.
Further learning
Next, the conversation that tests all of this: communicating bad news.